Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients

Journal of Neuroimmunology

Volumn 148, Issue 1-2, 2004, Pages 218-230

  Teutsch, Suzy M ^a   Booth, David R ^a   Bennetts, Bruce H ^b   Heard, Robert N S ^a   Stewart, Graeme J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

CD28; CD80; CD86; CTLA 4; Multiple sclerosis; Polymorphisms

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLELE; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC SCREENING; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION;

EID: 1242295125     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.12.003     Document Type: Article

References (97)

1. Ahmed S., Ihara K., Kanemitsu S., Nakashima H., Otsuka T., Tsuzaka K., Takeuchi T., Hara T. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology. 40:2001;662-667.
2. Akesson E., Oturai A., Berg J., Fredrikson S., Andersen O., Harbo H.F., Laaksonen M., Myhr K.M., Nyland H.I., Ryder L.P., Sandberg-Wollheim M., Sorensen P.S., Spurkland A., Svejgaard A., Holmans P., Compston A., Hillert J., Sawcer S. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun. 3:2002;279-285.
3. Alizadeh M., Babron M.C., Birebent B., Matsuda F., Quelvennec E., Liblau R., Cournu-Rebeix I., Momigliano-Richiardi P., Sequeiros J., Yaouanq J., Genin E., Vasilescu A., Bougerie H., Trojano M., Martins Silva B., Maciel P., Clerget-Darpoux F., Clanet M., Edan G., Fontaine B., Semana G. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann. Neurol. 54:2003;119-122.
4. Andreevskii T.V., Sudomoina M.A., Gusev E.I., Boiko A.N., Alekseenkov A.D., Favorova O.O. Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians. Mol. Biol. (Mosk.). 36:2002;643-648.
5. Anjos S., Nguyen A., Ounissi-Benkalha H., Tessier M.C., Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J. Biol. Chem. 277:2002;46478-46486.
6. Ban M., Stewart G.J., Bennetts B.H., Heard R., Simmons R., Maranian M., Compston A., Sawcer S.J. A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun. 3:2002;464-469.
7. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddison W.E., McFarland H.F., Trent J.M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9979-9984.
8. Becker N., Nieters A., Rittgen W. Single nucleotide polymorphism-disease relationships: statistical issues for the performance of association studies. Mutat. Res. 525:2003;11-18.
9. Bednarczuk T., Hiromatsu Y., Fukutani T., Jazdzewski K., Miskiewicz P., Osikowska M., Nauman J. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur. J. Endocrinol. 148:2003;13-18.
10. Bocko D., Bilinska M., Dobosz T., Zoledziewska M., Suwalska K., Tutak A., Gruszka E., Frydecka I. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region. Arch. Immunol. Ther. Exp. (Warsz.). 51:2003;201-205.
11. Boylan M.T., Crockard A.D., McDonnell G.V., Armstrong M.A., Hawkins S.A. CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone. J. Neurol. Sci. 167:1999;79-89.
12. Broadley S., Sawcer S., D'Alfonso S., Hensiek A., Coraddu F., Gray J., Roxburgh R., Clayton D., Buttinelli C., Quattrone A., Trojano M., Massacesi L., Compston A. A genome screen for multiple sclerosis in Italian families. Genes Immun. 2:2001;205-210.
13. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:2002;29-53.
14. Cocco E., Fadda E., Rolesu M., Melis C., Solla E., Schirru L., Costa G., Murru R., Marrosu M. Lack of association between CTLA-4 gene polymorphisms and multiple sclerosis in Sardinian patients. Mult. Scler. 8(Suppl. 1):2002;S119.
15. Colhoun H.M., McKeigue P.M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 361:2003;865-872.
16. Cross A.H., San M., Keeling R.M., Karr R.W. CTLA-Fc treatment of ongoing EAE improves recovery, but has no effect on the relapse rate. Implications for mechanisms involved in disease perpetuation. J. Neuroimmunol. 96:1999;144-147.
17. Delneste Y., Bosotti R., Magistrelli G., Bonnefoy J.Y., Gauchat J.F. Detection of a polymorphism in exon 8 of the human CD86 gene. Immunogenetics. 51:2000;762-763.
18. Deshpande M., Venuprasad K., Parab P.B., Saha B., Mitra D. A novel CD28 mRNA variant and simultaneous presence of various CD28 mRNA isoforms in human T lymphocytes. Hum. Immunol. 63:2002;20-23.
19. Djilali-Saiah I., Schmitz J., Harfouch-Hammoud E., Mougenot J.F., Bach J.F., Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut. 43:1998;187-189.
20. Djilali-Saiah I., Ouellette P., Caillat-Zucman S., Debray D., Kohn J.I., Alvarez F. CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis. Hum. Immunol. 62:2001;1356-1362.
21. Donner H., Rau H., Walfish P.G., Braun J., Siegmund T., Finke R., Herwig J., Usadel K.H., Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Grave's disease and to Type 1 Diabetes mellitus. J. Clin. Endocrinol. Metab. 82:1997;143-146.
22. Donner H., Braun J., Seidl C., Rau H., Finke R., Ventz M., Walfish P.G., Usadel K.H., Badenhoop K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab. 82:1997;4130-4132.
23. Dyment D.A., Steckley J.L., Willer C.J., Armstrong H., Sadovnick A.D., Risch N., Ebers G.C. No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study. J. Neuroimmunol. 123:2002;193-198.
24. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R., Hader W., Paty D., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., Metz L., Francis G., Paulseth J., Murray T., Pryse-Phillips W., Nelson R., Freedman M., Brunet D., Bouchard J.-P., Hinds D., Risch N. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-480.
25. Epplen C., Jackel S., Santos E.J., D'Souza M., Poehlau D., Dotzauer B., Sindern E., Haupts M., Rude K.P., Weber F., Stover J., Poser S., Gehler W., Malin J.P., Przuntek H., Epplen J.T. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. Ann. Neurol. 41:1997;341-352.
26. Filion L.G., Matusevicius D., Graziani-Bowering G.M., Kumar A., Freedman M.S. Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis. Clin. Immunol. 106:2003;127-138.
27. Fukazawa T., Yanagawa T., Kikuchi S., Yabe I., Sasaki H., Hamada T., Miyasaka K., Gomi K., Tashiro K. CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients. J. Neurol. Sci. 171:1999;49-55.
28. Genc K., Dona D.L., Reder A.T. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J. Clin. Invest. 99:1997;2664-2671.
29. Giorelli M., Livrea P., Defazio G., Ricchiuti F., Pagano E., Trojano M. IFN-beta1a modulates the expression of CTLA-4 and CD28 splice variants in human mononuclear cells: induction of soluble isoforms. J. Interferon Cytokine Res. 21:2001;809-812.
30. Gonzalez-Escribano M.F., Rodriguez R., Valenzuela A., Garcia A., Garcia-Lozano J.R., Nuñez-Roldan A. CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens. 53:1999;296-300.
31. Haines J., Pericak-Vance M., Seboun E., Hauser S., Group T.M.S.G. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:1996;469-471.
32. Hanawa H., Ma Y., Mikolajczak S.A., Charles M.L., Yoshida T., Yoshida R., Strathdee C.A., Litchfield D.W., Ochi A. A novel costimulatory signaling in human T lymphocytes by a splice variant of CD28. Blood. 99:2002;2138-2145.
33. Harbo H.F., Celius E.G., Vartdal F., Spurkland A. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens. 53:1999;106-110.
34. Heggarty S.V., Silversides J., Vandenbroeck K., McDonnell G., Hawkins S., Graham C. CTLA-4 gene polymorphisms and their influence on susceptibility to multiple sclerosis in N. Ireland. Mult. Scler. 8(Suppl. 1):2002;S64.
35. Hudson L.L., Rocca K., Song Y.W., Pandey J.P. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum. Genet. 111:2002;452-455.
36. Hurwitz A.A., Sullivan T.J., Sobel R.A., Allison J.P. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;3013-3017.
37. Ihara K., Ahmed S., Nakao F., Kinukawa N., Kuromaru R., Matsuura N., Iwata I., Nagafuchi S., Kohno H., Miyako K., Hara T. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics. 53:2001;447-454.
38. John S.W., Weitzner G., Rozen R., Scriver C.R. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res. 19:1991;408.
39. Johnson G.C., Esposito L., Barratt B.J., Smith A.N., Heward J., Di Genova G., Ueda H., Cordell H.J., Eaves I.A., Dudbridge F., Twells R.C., Payne F., Hughes W., Nutland S., Stevens H., Carr P., Tuomilehto-Wolf E., Tuomilehto J., Gough S.C., Clayton D.G., Todd J.A. Haplotype tagging for the identification of common disease genes. Nat. Genet. 29:2001;233-237.
40. Kantarci O.H., de Andrade M., Weinshenker B.G. Identifying disease modifying genes in multiple sclerosis. J. Neuroimmunol. 123:2002;144-159.
41. Kantarci O.H., Hebrink D.D., Achenbach S.J., Atkinson E.J., Waliszewska A., Buckle G., McMurray C.T., de Andrade M., Hafler D.A., Weinshenker B.G. CTLA4 is associated with susceptibility to multiple sclerosis. J. Neuroimmunol. 134:2003;133-141.
42. Karandikar N.J., Eagar T.N., Vanderlugt C.L., Bluestone J.A., Miller S.D. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 109:2000;173-180.
43. Kouki T., Sawai Y., Gardine C.A., Fisfalen M.E., Alegre M.L., DeGroot L.J. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J. Immunol. 165:2000;6606-6611.
44. Kristiansen O.P., Larsen Z.M., Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun. 1:2000;170-184.
45. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., Wikstrom J., Palo J., Stein L.D., Hudson T.J., Lander E.S., Peltonen L. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61:1997;1379-1387.
46. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19:1991;5444.
47. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
48. Liang B., Gee R.J., Kashgarian M.J., Sharpe A.H., Mamula M.J. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. J. Immunol. 163:1999;2322-2329.
49. Ligers A., Chun X., Saarinen S., Hillert J., Olerup O. The CTLA-4 gene is associated with multiple sclerosis. J. Neuroimmunol. 97:1999;182-190.
50. Ligers A., Teleshova N., Masterman T., Huang W.X., Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2:2001;145-152.
51. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33:2003;177-182.
52. Magistrelli G., Jeannin P., Elson G., Gauchat J.F., Nguyen T.N., Bonnefoy J.Y., Delneste Y. Identification of three alternatively spliced variants of human CD28 mRNA. Biochem. Biophys. Res. Commun. 259:1999;34-37.
53. Masterman T., Ligers A., Zhang Z., Hellgren D., Salter H., Anvret M., Hillert J. CTLA4 dimorphisms and the multiple sclerosis phenotype. J. Neuroimmunol. 131:2002;208-212.
54. Matsushita M., Tsuchiya N., Oka T., Yamane A., Tokunaga K. New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus. Genes Immun. 1:2000;428-434.
55. Mäurer M., Loserth S., Kolb-Mäurer A., Ponath A., Wiese S., Kruse N., Rieckmann P. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1+49) alters T-cell activation. Immunogenetics. 54:2002;1-8.
56. Mäurer M., Ponath A., Kruse N., Rieckmann P. CTLA4 exon 1 dimorphism is associated with primary progressive multiple sclerosis. J. Neuroimmunol. 131:2002;213-215.
57. McCoy K.D., Le Gros G. The role of CTLA-4 in the regulation of T cell immune responses. Immunol. Cell Biol. 77:1999;1-10.
58. Mena E., Rohowsky-Kochan C. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis. Acta Neurol. Scand. 100:1999;92-96.
59. Mertens C., Brassat D., Reboul J., Eichenbaum-Voline S., Vuillemin-Azais C., Cournu I., Babron M.C., Semana G., Edan G., Clanet M., Clerget-Darpoux F., Baron-Van Evercooren A., Lyon-Caen O., Liblau R., Fontaine B. A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics Group. Neurology. 51:1998;748-753.
60. Miterski B., Bohringer S., Klein W., Sindern E., Haupts M., Schimrigk S., Epplen J.T. Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations. Genes Immun. 3:2002;211-219.
61. Monteyne P., Guillaume B., Sindic C.J. B7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor-beta mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients. J. Neuroimmunol. 91:1998;198-203.
62. Mora B., Bonamico M., Indovina P., Megiorni F., Ferri M., Carbone M.C., Cipolletta E., Mazzilli M.C. CTLA-4 +49 A/G dimorphism in Italian patients with celiac disease. Hum. Immunol. 64:2003;297-301.
63. Nistico L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., Larrad M.T., Rios M.S., Chow C.C., Cockram C.S., Jacobs K., Mijovic C., Bain S.C., Barnett A.H., Vandewalle C.L., Schuit F., Gorus F.K., Tosi R., Pozzilli P., Todd J.A. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 5:1996;1075-1080.
64. Nithiyananthan R., Heward J.M., Allahabadia A., Franklyn J.A., Gough S.C. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid. 12:2002;3-6.
65. Oliveira E.M., Bar-Or A., Waliszewska A.I., Cai G., Anderson D.E., Krieger J.I., Hafler D.A. CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls. J. Autoimmun. 20:2003;71-81.
66. Palmer E. Negative selection - clearing out the bad apples from the T-cell repertoire. Nat. Rev. Immunol. 3:2003;383-391.
67. Pavkovic M., Georgievski B., Cevreska L., Spiroski M., Efremov D.G. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders. Am. J. Hematol. 72:2003;147-149.
68. Perrin P.J., Scott D., Quigley L., Albert P.S., Feder O., Gray G.S., Abe R., June C.H., Racke M.K. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154:1995;1481-1490.
69. Perrin P.J., June C.H., Maldonado J.H., Ratts R.B., Racke M.K. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 163:1999;1704-1710.
70. Poser C.M., Sheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberg D.H., Tourtelotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
71. Prud'homme G.J., Chang Y., Li X. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand. Hum. Gene Ther. 13:2002;395-406.
72. Pullmann R. Jr., Lukac J., Skerenova M., Rovensky J., Hybenova J., Melus V., Celec S., Pullmann R., Hyrdel R. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 17:1999;725-729.
73. Quattrocchi E., Dallman M.J., Feldmann M. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis. Arthritis Rheum. 43:2000;1688-1697.
74. Rasmussen H.B., Kelly M.A., Francis D.A., Clausen J. CTLA4 in multiple sclerosis. Lack of association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese. J. Neurol. Sci. 184:2001;143-147.
75. Schrijver H.M., Crusius J.B., Uitdehaag B.M., Garcia Gonzalez M.A., Kostense P.J., Polman C.H., Pena A.S. Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology. 52:1999;595-599.
76. Seidl C., Donner H., Fischer B., Usadel K.H., Seifried E., Kaltwasser J.P., Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens. 51:1998;62-66.
77. Sellebjerg F., Jensen J., Ryder L.P. Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis. J. Neuroimmunol. 84:1998;179-187.
78. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitis (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
79. Srinivasan M., Gienapp I.E., Stuckman S.S., Rogers C.J., Jewell S.D., Kaumaya P.T., Whitacre C.C. Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28. J. Immunol. 169:2002;2180-2188.
80. Svejgaard A., Hauge M., Jersild C., Platz P., Ryder L.P., Staub-Nielsen L., Thomsen M. The HLA system. Monogr. Hum. Genet. 7:1979;1-111.
81. Teutsch S.M., Booth D.R., Bennetts B.H., Heard R.N., Stewart G.J. Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis. Eur. J. Hum. Genet. 11:2003;509-515.
82. Tivol E.A., Schweitzer A.N., Sharpe A.H. Costimulation and autoimmunity. Curr. Opin. Immunol. 8:1996;822-830.
83. Tiwari J.L., Terasaki P.I. The Data and Statistical Analysis. 1985;Springer-Verlag, New York.
84. Torinsson Naluai Å., Nilsson S., Samuelsson L., Gudjónsdóttir A.H., Ascher H., Elk J., Hallberg B., Kristiansson B., Martinsson T., Nerman O., Sollid L.M., Wahlström J. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders. Tissue Antigens. 56:2000;350-355.
85. Turner D., Choudhury F., Reynard M., Railton D., Navarrete C. Typing of multiple single nucleotide polymorphisms in cytokine and receptor genes using SNaPshot. Hum. Immunol. 63:2002;508-513.
86. Turpeinen H., Laine A.P., Nejentsev S., Sjoroos M., Ilonen J., Simell O., Veijola R., Knip M., Akerblom H.K. CD86 gene polymorphisms: no association with Type I diabetes among Finnish subjects. Diabetologia. 45:2002;1041-1042.
87. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., Rainbow D.B., Hunter K.M., Smith A.N., Di Genova G., Herr M.H., Dahlman I., Payne F., Smyth D., Lowe C., Twells R.C., Howlett S., Healy B., Nutland S., Rance H.E., Everett V., Smink L.J., Lam A.C., Cordell H.J., Walker N.M., Bordin C., Hulme J., Motzo C., Cucca F., Hess J.F., Metzker M.L., Rogers J., Gregory S., Allahabadia A., Nithiyananthan R., Tuomilehto-Wolf E., Tuomilehto J., Bingley P., Gillespie K.M., Undlien D.E., Ronningen K.S., Guja C., Ionescu-Tirgoviste C., Savage D.A., Maxwell A.P., Carson D.J., Patterson C.C., Franklyn J.A., Clayton D.G., Peterson L.B., Wicker L.S., Todd J.A., Gough S.C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:2003;506-511. (advance online publication, 30 April 2003 (doi:10.1038/nature01621)).
88. van Veen T., Crusius J.B., van Winsen L., Xia B., Barkhof F., Salvador Pena A., Polman C.H., Uitdehaag B.M. CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis. J. Neuroimmunol. 140:2003;188-193.
89. Vasu C., Gorla S.R., Prabhakar B.S., Holterman M.J. Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. Int. Immunol. 15:2003;641-654.
90. Wandstrat A., Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2:2001;802-809.
91. Wang X.B., Kakoulidou M., Qiu Q., Giscombe R., Huang D., Pirskanen R., Lefvert A.K. CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis. Genes Immun. 3:2002;46-49.
92. Wang X.B., Zhao X., Giscombe R., Lefvert A.K. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun. 3:2002;233-234.
93. Weinshenker B.G., Hebrink D.D., Klein C., Atkinson E.J., O'Brien P.C., McMurray C.T. Genetic variation in the B7-1 gene in patients with multiple sclerosis. J. Neuroimmunol. 105:2000;184-188.
94. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., Hafler D. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.
95. Wingender E., Chen X., Hehl R., Karas H., Liebich I., Matys V., Meinhardt T., Pruss M., Reuter I., Schacherer F. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res. 28:2000;316-319.
96. Wood J.P., Pani M.A., Bieda K., Meyer G., Usadel K.H., Badenhoop K. A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes. Eur. J. Immunogenet. 29:2002;347-349.
97. Zhou J., Zhang J.S., Ma B.L., Mamula M.J. Experimental autoimmune encephalomyelitis in the Wistar rat: dependence of MBP-specific T cell responsiveness on B7 costimulation. Autoimmunity. 35:2002;191-199.